Recon: Biogen to pay $900M to resolve physician kickback claims; FDA places partial hold on Avidity’s muscle disorder drug
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy